Corvus Pharmaceuticals (CRVS) Financial Statements

Compare

676 Followers

Corvus Pharmaceuticals Financial Overview

Corvus Pharmaceuticals's market cap is currently $1.18B. The company's EPS TTM is $-0.15; its P/E ratio is -39.78; Corvus Pharmaceuticals is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -105.00K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -42.97M	$ -27.55M	$ -23.41M	$ -32.56M	$ -38.63M
EBITDA	$ -42.97M	$ -27.46M	$ -23.26M	$ -32.20M	$ -38.17M
Net Income	$ -15.28M	$ -62.29M	$ -27.03M	$ -41.31M	$ -43.24M
Balance Sheet
Cash & Short-Term Investments	$ 56.75M	$ 51.96M	$ 27.15M	$ 42.30M	$ 69.45M
Total Assets	$ 71.12M	$ 68.91M	$ 45.55M	$ 68.24M	$ 109.45M
Total Debt	$ 937.00K	$ 1.12M	$ 1.37M	$ 2.60M	$ 3.65M
Net Debt	$ -3.64M	$ -7.62M	$ -11.25M	$ -10.56M	$ -59.81M
Total Liabilities	$ 9.91M	$ 36.34M	$ 6.87M	$ 12.13M	$ 12.29M
Stockholders' Equity	$ 61.20M	$ 32.57M	$ 38.68M	$ 56.12M	$ 97.16M
Cash Flow
Free Cash Flow	$ -32.97M	$ -25.42M	$ -23.97M	$ -27.29M	$ -36.72M
Operating Cash Flow	$ -32.80M	$ -25.42M	$ -23.93M	$ -27.02M	$ -36.72M
Investing Cash Flow	$ -7.80M	$ -27.48M	$ 15.54M	$ -23.28M	$ 21.56M
Financing Cash Flow	$ 36.43M	$ 49.03M	$ 7.86M	$ 0.00	$ 62.16M

Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History

Income Statement >

Corvus Pharmaceuticals Debt to Assets

Balance Sheet >

Corvus Pharmaceuticals Cash Flow

Cash Flow >

Corvus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >